Predicting ADMET Properties from Molecule SMILE: A Bottom-Up Approach Using Attention-Based Graph Neural Networks

Alessandro De Carlo,Davide Ronchi,Marco Piastra,Elena Maria Tosca,Paolo Magni
DOI: https://doi.org/10.3390/pharmaceutics16060776
IF: 6.525
2024-06-08
Pharmaceutics
Abstract:Understanding the pharmacokinetics, safety and efficacy of candidate drugs is crucial for their success. One key aspect is the characterization of absorption, distribution, metabolism, excretion and toxicity (ADMET) properties, which require early assessment in the drug discovery and development process. This study aims to present an innovative approach for predicting ADMET properties using attention-based graph neural networks (GNNs). The model utilizes a graph-based representation of molecules directly derived from Simplified Molecular Input Line Entry System (SMILE) notation. Information is processed sequentially, from substructures to the whole molecule, employing a bottom-up approach. The developed GNN is tested and compared with existing approaches using six benchmark datasets and by encompassing regression (lipophilicity and aqueous solubility) and classification (CYP2C9, CYP2C19, CYP2D6 and CYP3A4 inhibition) tasks. Results show the effectiveness of our model, which bypasses the computationally expensive retrieval and selection of molecular descriptors. This approach provides a valuable tool for high-throughput screening, facilitating early assessment of ADMET properties and enhancing the likelihood of drug success in the development pipeline.
pharmacology & pharmacy
What problem does this paper attempt to address?
The paper aims to address the prediction of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties in the drug development process. Specifically, the research goal is to develop an innovative approach using attention-based Graph Neural Networks (GNNs) to predict the ADMET properties of molecules. This method extracts information directly from the Simplified Molecular Input Line Entry System (SMILES) representation and processes molecular structures in a bottom-up manner, analyzing from substructures to the entire molecule step by step. Key points of the paper include: - **Research Background**: Drug development is a time-consuming and costly process, where ADMET properties are crucial for the success of a drug. Traditional experimental methods are expensive and difficult to scale, thus efficient and low-cost computational methods are needed for high-throughput screening. - **Technical Solution**: The paper proposes an attention-based Graph Neural Network model that can avoid the need for molecular descriptors in traditional methods, thereby reducing computational complexity. - **Datasets and Evaluation**: To validate the effectiveness of the proposed model, the authors tested it on 6 benchmark datasets, covering regression tasks (such as lipophilicity and aqueous solubility prediction) and classification tasks (such as CYP enzyme inhibition activity prediction). The model performance was evaluated using 5-fold cross-validation. - **Contributions and Significance**: This study provides an efficient tool that can quickly assess the ADMET properties of candidate drugs in the early stages of drug discovery, helping to increase the success rate of drug development and reduce costs. In summary, the main goal of this paper is to demonstrate a novel GNN-based method for ADMET property prediction, which not only improves prediction accuracy but also simplifies the computational process, potentially accelerating the drug development process.